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Introduction
Three key features are representative for systemic sclero-
sis (SSc), including (i) prevalent vascular lesions and
endothelial dysfunction, (ii) fibrosis and (iii) immune
abnormalities with consequent occlusive vascular compli-
cations. Insufficiently data is actually provided about lipid
profile and possible implication in vascular disorder
in SSc.
Aims
To investigate potential involvement of lipid abnormal-
ities in onset and progression of vascular occlusive com-
plication in SSc.
Patients and methods
53 consecutive SSc and 50 matched healthy controls were
enrolled in this study; assessments included (i) lipid profile
(total cholesterol TC, low- and high-density lipoprotein
cholesterol LDL-C, HDL-C, triglycerides TG, atherogenic
index, lipoprotein A LpA), and (ii) high-sensitive C reac-
tive protein (Hs-CRP).
Lipid levels of risk were determined in accordance
with NCEP and AHA/ACC; statistical analysis was done
in SPSS-17, p<0.05.
Results
Significantly lower HDL-C and TC (p<0.05), higher risk
HDL, LpA and Hs-CRP levels were identified in SSc
(44.7% vs.8.2%; 33.9% vs 4.1%; 42% vs. 9.8, p<0.05).
Anti-SCL70 antibodies positivity was associated with
lower HDL-C (p<0.05), while pulmonary hypertension
but no other clinical feature was associated with low
HDL-C (p<0.05).
Conclusions
Adverse lipid pattern, especially low HDL-C, is com-
monly reported in SSc, particularly anti-SCL70-positive
forms; the significance for early accelerated athero-
sclerosis and the identification of patients predisposed
to commonly develop thrombotic complications remain
to be validated by future studies.
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